TSC107J #5, TSC#14 clone 107J#5	
    			    			
                IMBAi021-A            
            
        General
| Cell Line | |
| hPSCreg name | IMBAi021-A | 
| Cite as: | IMBAi021-A | 
| Alternative name(s) | 
	TSC107J #5, TSC#14 clone 107J#5	 | 
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | No similar lines found. | 
| Last update | 24th April 2025 | 
| User feedback | |
| Provider | |
| Generator | Institute of Molecular Biotechnology (IMBA) | 
| Derivation country | Austria | 
| External Databases | |
| BioSamples | SAMEA117616009 | 
| General Information | |
| Publications | |
| * Is the cell line readily obtainable for third parties? | Yes Research use: allowed Clinical use: not allowed Commercial use: allowed | 
Donor Information
| General Donor Information | |
| Sex | female | 
| Phenotype and Disease related information (Donor) | |
| Diseases | A disease was diagnosed. | 
| Karyotyping (Donor) | |
| Has the donor karyotype been analysed? | Yes 
												46,XX
											 
											Karyotyping method:
											Molecular karyotyping by SNP array											
											 http:// | 
| External Databases (Donor) | |
| BioSamples | SAMEA117616010 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No | 
| If you do not hold the Donor Consent Form, do you know who does? | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| * Does consent expressly prevent the derivation of pluripotent stem cells? | No | 
| * Does consent pertain to a specific research project? | No | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No | 
| Does consent permit research by | |
| an academic institution? | Yes | 
| a public organisation? | Yes | 
| a non-profit company? | Yes | 
| a for-profit corporation? | Yes | 
| How may genetic information associated with the cell line be accessed? | Controlled Access | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | Ethikkommission der Medizinischen Universität Wien | 
| Approval number | EK 1226/2017 | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
hIPSC Derivation
| General | |
| Source cell type | A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes. Synonyms 
 | 
| Reprogramming method | |
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Genes | |
| Is reprogramming vector detectable? | No | 
| Methods used | 
	RT-PCR	 | 
| Vector free reprogramming | |
| Other | |
| Derived under xeno-free conditions | No | 
| Derived under GMP? | No | 
| Available as clinical grade? | No | 
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Medium | mTeSR™ Plus | 
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes | 
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| SSEA5 | Yes |  | ||||
| SSEA-4 | Yes |  | ||||
| Alkaline Phosphatase | Yes |  | 
Differentiation Potency
In vitro directed differentiation
					In vitro directed differentiation
					| Microbiology / Virus Screening | |
| HIV 1 | Negative | 
| HIV 2 | Negative | 
| Hepatitis B | Negative | 
| Hepatitis C | Negative | 
| Mycoplasma | Negative | 
Genotyping
| Karyotyping (Cell Line) | |
| Has the cell line karyotype been analysed? | Yes 
												46,XX
											 
											Karyotyping method:
											Molecular karyotyping by SNP array											
											 http:// | 
| Other Genotyping (Cell Line) | |

Login to share your feedback, experiences or results with the research community.